|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_NoncurrentFinancialAssetAcquisitionAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_BoardDecisionDateForAcquisition|
|
|
22/12/2025
|
|||||||
|
oda_WereMajorityOfIndependentBoardMembersApprovedTheBoardDecisionForAcquisition|
|
|
Yes
|
|||||||
|
oda_TitleOfNoncurrentFinancialAssetAcquired|
|
|
Altera Medikal Sanayi ve Ticaret Anonim Şirketi
|
|||||||
|
oda_FieldOfActivityNoncurrentFinancialAssetWhoseSharesWereAcquired|
|
|
Production, Marketing, and Sale of Medical Supplies and Medical Parts from Silicone and Plastic-Based Raw Materials
|
|||||||
|
oda_CapitalOfNoncurrentFinancialAsset|
|
|
TRY 75,000,000
|
|||||||
|
oda_AcquirementWay|
|
|
Satın Alma (Purchase)
|
|||||||
|
oda_DateOnWhichTheTransactionWasWillBeCompleted|
|
|
22/12/2025
|
|||||||
|
oda_AcquisitionConditions|
|
|
Diğer (Other)
|
|||||||
|
oda_DetailedConditionsIfItIsATimedPayment|
|
|
-
|
|||||||
|
oda_NominalValueOfSharesAcquired|
|
|
TRY 13,500,000
|
|||||||
|
oda_PurchasePricePerShare|
|
|
TRY 1.00
|
|||||||
|
oda_TotalPurchasingValue|
|
|
TRY 13,500,000
|
|||||||
|
oda_RatioOfNewSharesAcquiredToCapitalOfNoncurrentFinancialAsset|
|
|
18%
|
|||||||
|
oda_TotalRatioOfSharesOwnedInCapitalOfNoncurrentFinancialAssetAfterTransaction|
|
|
100%
|
|||||||
|
oda_TotalVotingRightRatioOwnedInNoncurrentFinancialAssetAfterTransaction|
|
|
100%
|
|||||||
|
oda_RatioOfNoncurrentFinancialAssetAcquiredToTotalAssetsInLatestDisclosedFinancialStatementsOfCompany|
|
|
0,38%
|
|||||||
|
oda_RatioOfTransactionValueToSalesInLatestAnnualFinancialStatementsOfCompany|
|
|
0,64%
|
|||||||
|
oda_EffectsOnCompanyOperations|
|
|
None.
|
|||||||
|
oda_DidTakeoverBidObligationArised|
|
|
Hayır (No)
|
|||||||
|
oda_WillExemptionApplicationBeMadeIfTakeoverBidObligationArised|
|
|
Hayır (No)
|
|||||||
|
oda_TitleNameSurnameOfCounterParty|
|
|
Mert SEVİNÇLİ
|
|||||||
|
oda_IsCounterPartyARelatedPartyAccordingToCMBRegulations|
|
|
Evet (Yes)
|
|||||||
|
oda_RelationWithCounterPartyIfAny|
|
|
A shareholder of our company with a 23.03% stake
|
|||||||
|
oda_AgreementSigningDateIfExists|
|
|
22/12/2025
|
|||||||
|
oda_ValueDeterminationMethodOfNoncurrentFinancialAsset|
|
|
Determined based on the negotiations between the parties.
|
|||||||
|
oda_DidValuationReportBePrepared|
|
|
Düzenlenmedi (Not Prepared)
|
|||||||
|
oda_ReasonForNotPreparingValuationReportIfItWasNotPrepared|
|
|
Not mandatory according to the applicable regulations.
|
|||||||
|
oda_DateAndNumberOfValuationReport|
|
|
-
|
|||||||
|
oda_TitleOfValuationCompanyPreparedReport|
|
|
-
|
|||||||
|
oda_ValueDeterminedInValuationReportIfExists|
|
|
-
|
|||||||
|
oda_ReasonsIfTransactionWasntWillNotBePerformedInAccordanceWithValuationReport|
|
|
-
|
|||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
At the meeting of our company's Board of Directors on December 22, 2025; Our company owns an 82% stake in our affiliate Altera Medikal Sanayi ve Ticaret A.Ş., located at İbni Melek Osb Mahallesi Tosbi Yol 4 Sokak N 31/1 Tire, İZMİR. It has been decided to purchase a 13,500,000 TL (equivalent to an 18.00% shareholding) from Mert Sevinçli for a total consideration of 13,500,000 TL.
The transfer of shares belonging to Altera Medikal Sanayi ve Ticaret A.Ş. has been completed and registered by the Tire Trade Registry Office as of December 22, 2025, and announced in the Turkish Trade Registry Gazette dated December 22, 2025, and numbered 11484.
The share transfer fee of 11,047,500.00 TL has been paid in advance, and the remaining portion will be paid as a capital debt within 17 months in accordance with the transaction stated in our Company's Special Situation Disclosure dated May 20, 2025.
This decision was made in line with our company's strategic objectives and currently has no impact on cash flow or operational activities.
It is respectfully announced to the public.
This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.
|
||||||||